| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $231.7M | +0.7% |
| Cost of Revenue | $179.8M | +0.8% |
| Gross Profit | $51.9M | +0.5% |
| R&D Expense | $51.2M | -0.7% |
| SG&A Expense | $47.1M | -2.8% |
| Operating Income | -$53.0M | +8.0% |
| Pre-tax Income | -$62.6M | -31.7% |
| Income Tax | -$8.3M | +23.8% |
| Net Income | -$54.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $138.6M | -12.3% |
| Accounts Receivable | $28.4M | -13.0% |
| Inventory | $30.5M | -6.7% |
| Current Assets | $219.2M | -10.7% |
| Total Assets | $379.3M | -9.8% |
| Current Liabilities | $46.3M | -1.3% |
| Long-term Debt | $27.2M | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.1M | -103.5% |
| Capital Expenditures | $11.6M | +66.8% |
| Investing Cash Flow | -$11.7M | -52.4% |
| Financing Cash Flow | $16.6M | +131.6% |
| Free Cash Flow | -$17.7M | -77.9% |
| -48.3% |
| EPS (Basic) | -$1.44 | -61.8% |
| EPS (Diluted) | -$1.44 | -61.8% |
| Total Liabilities |
| $102.5M |
| +35.1% |
| Stockholders' Equity | $276.8M | -19.7% |